{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:55:17Z","timestamp":1784782517185,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Luitpold Pharmaceuticals, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10620-018-5204-3","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T11:31:03Z","timestamp":1532777463000},"page":"3009-3019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron"],"prefix":"10.1007","volume":"63","author":[{"given":"Gary R.","family":"Lichtenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"key":"5204_CR1","unstructured":"World Health Organization, Centers for Disease Control and Prevention. Worldwide prevalence of anaemia 1993\u20132005: WHO global database on anaemia. In: de Benoist B, McLean E, Egli I, Cogswell M, eds. Geneva: World Health Organization; 2008."},{"key":"5204_CR2","doi-asserted-by":"publisher","first-page":"a011866","DOI":"10.1101\/cshperspect.a011866","volume":"3","author":"JL Miller","year":"2013","unstructured":"Miller JL. Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med. 2013;3:a011866.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5204_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.hoc.2015.11.002","volume":"30","author":"NJ Kassebaum","year":"2016","unstructured":"Kassebaum NJ. The global burden of anemia. Hematol Oncol Clin North Am. 2016;30:247\u2013308.","journal-title":"Hematol Oncol Clin North Am"},{"key":"5204_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2011.06.005","volume":"141","author":"R Evstatiev","year":"2011","unstructured":"Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:e1\u2013e2.","journal-title":"Gastroenterology"},{"key":"5204_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s40265-013-0131-2","volume":"73","author":"F Gomollon","year":"2013","unstructured":"Gomollon F, Gisbert JP. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs. 2013;73:1761\u20131770.","journal-title":"Drugs"},{"key":"5204_CR6","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3748\/wjg.v16.i22.2720","volume":"16","author":"UD Bayraktar","year":"2010","unstructured":"Bayraktar UD, Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J Gastroenterol. 2010;16:2720\u20132725.","journal-title":"World J Gastroenterol"},{"key":"5204_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/MIB.0000000000000648","volume":"22","author":"N Murawska","year":"2016","unstructured":"Murawska N, Fabisiak A, Fichna J. Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflamm Bowel Dis. 2016;22:1198\u20131208.","journal-title":"Inflamm Bowel Dis"},{"key":"5204_CR8","doi-asserted-by":"publisher","first-page":"7908","DOI":"10.3748\/wjg.v22.i35.7908","volume":"22","author":"J Stein","year":"2016","unstructured":"Stein J, Connor S, Virgin G, Ong DE, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol. 2016;22:7908\u20137925.","journal-title":"World J Gastroenterol"},{"key":"5204_CR9","first-page":"691","volume":"94","author":"G Bottaro","year":"1999","unstructured":"Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical\/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol. 1999;94:691\u2013696.","journal-title":"Am J Gastroenterol"},{"key":"5204_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/00365529509093254","volume":"30","author":"GR Corazza","year":"1995","unstructured":"Corazza GR, Valentini RA, Andreani ML, et al. Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol. 1995;30:153\u2013156.","journal-title":"Scand J Gastroenterol"},{"key":"5204_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1023\/A:1018896015530","volume":"43","author":"A Carroccio","year":"1998","unstructured":"Carroccio A, Iannitto E, Cavataio F, et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci. 1998;43:673\u2013678.","journal-title":"Dig Dis Sci"},{"key":"5204_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/jcp.55.10.754","volume":"55","author":"MR Howard","year":"2002","unstructured":"Howard MR, Turnbull AJ, Morley P, Hollier P, Webb R, Clarke A. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 2002;55:754\u2013757.","journal-title":"J Clin Pathol"},{"key":"5204_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis.. 2015;9:211\u2013222.","journal-title":"J Crohns Colitis."},{"key":"5204_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","volume":"103","author":"S Kulnigg","year":"2008","unstructured":"Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103:1182\u20131192.","journal-title":"Am J Gastroenterol"},{"key":"5204_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10620-014-3460-4","volume":"60","author":"T Iqbal","year":"2015","unstructured":"Iqbal T, Stein J, Sharma N, Kulnigg-Dabsch S, Vel S, Gasche C. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia. Dig Dis Sci. 2015;60:1375\u20131381.","journal-title":"Dig Dis Sci"},{"key":"5204_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1079\/BJN19940127","volume":"71","author":"DG Maxton","year":"1994","unstructured":"Maxton DG, Thompson RP, Hider RC. Absorption of iron from ferric hydroxypyranone complexes. Br J Nutr. 1994;71:203\u2013207.","journal-title":"Br J Nutr"},{"key":"5204_CR17","first-page":"515","volume":"18","author":"N Sharma","year":"2001","unstructured":"Sharma N. Iron absorption: IPC therapy is superior to conventional iron salts. Obstet Gynecol. 2001;18:515\u2013519.","journal-title":"Obstet Gynecol"},{"key":"5204_CR18","first-page":"754","volume":"40","author":"P Geisser","year":"1990","unstructured":"Geisser P. In vitro studies on interactions of iron salts and complexes with food-stuffs and medicaments. Arzneimittelforschung. 1990;40:754\u2013760.","journal-title":"Arzneimittelforschung"},{"key":"5204_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0140-6736(07)61235-5","volume":"370","author":"MB Zimmermann","year":"2007","unstructured":"Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007;370:511\u2013520.","journal-title":"Lancet"},{"key":"5204_CR20","first-page":"367","volume":"15","author":"P Jacobs","year":"1984","unstructured":"Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. J Med. 1984;15:367\u2013377.","journal-title":"J Med"},{"key":"5204_CR21","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","volume":"24","author":"S Kulnigg","year":"2006","unstructured":"Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn\u2019s disease. Aliment Pharmacol Ther. 2006;24:1507\u20131523.","journal-title":"Aliment Pharmacol Ther"},{"key":"5204_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ibd.20285","volume":"13","author":"C Gasche","year":"2007","unstructured":"Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545\u20131553.","journal-title":"Inflamm Bowel Dis"},{"key":"5204_CR23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1572-0241.2008.01846.x","volume":"103","author":"JP Gisbert","year":"2008","unstructured":"Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1299\u20131307.","journal-title":"Am J Gastroenterol"},{"key":"5204_CR24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1001\/jama.2015.15572","volume":"314","author":"C Wang","year":"2015","unstructured":"Wang C, Graham DJ, Kane RC, et al. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA. 2015;314:2062\u20132068.","journal-title":"JAMA"},{"key":"5204_CR25","doi-asserted-by":"publisher","first-page":"630519","DOI":"10.1155\/2012\/630519","volume":"2012","author":"AA Khalafallah","year":"2012","unstructured":"Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy. J Pregnancy. 2012;2012:630519.","journal-title":"J Pregnancy"},{"key":"5204_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ndt\/gfi253","volume":"21","author":"GM Chertow","year":"2006","unstructured":"Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transpl. 2006;21:378\u2013382.","journal-title":"Nephrol Dial Transpl"},{"key":"5204_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ajh.21794","volume":"85","author":"DK Wysowski","year":"2010","unstructured":"Wysowski DK, Swartz L, Borders-Hemphill BV, et al. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010;85:650\u2013654.","journal-title":"Am J Hematol"},{"key":"5204_CR28","unstructured":"Feraheme [package insert]. Waltham, MA: AMAG Pharmaceuticals, Inc., 2015."},{"key":"5204_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11695-013-0939-6","volume":"23","author":"M Malone","year":"2013","unstructured":"Malone M, Barish C, He A, et al. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients. Obes Surg. 2013;23:1413\u20131420.","journal-title":"Obes Surg"},{"key":"5204_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","volume":"69","author":"KA Lyseng-Williamson","year":"2009","unstructured":"Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs. 2009;69:739\u2013756.","journal-title":"Drugs"},{"key":"5204_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40265-014-0332-3","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating GM. Ferric carboxymaltose: a review of its use in iron deficiency. Drugs. 2015;75:101\u2013127.","journal-title":"Drugs"},{"key":"5204_CR32","unstructured":"Injectafer [package insert]. Shirley, NY: American Regent, Inc., July 2013."},{"key":"5204_CR33","doi-asserted-by":"publisher","first-page":"172104","DOI":"10.1155\/2012\/172104","volume":"2012","author":"CF Barish","year":"2012","unstructured":"Barish CF, Koch T, Butcher A, Morris D, Bregman DB. Safety and efficacy of intravenous ferric carboxymaltose (750\u00a0mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia. 2012;2012:172104.","journal-title":"Anemia"},{"key":"5204_CR34","doi-asserted-by":"publisher","first-page":"169107","DOI":"10.1155\/2013\/169107","volume":"2013","author":"I Hussain","year":"2013","unstructured":"Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB. Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia. 2013;2013:169107.","journal-title":"Anemia"},{"key":"5204_CR35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/trf.12289","volume":"54","author":"JE Onken","year":"2014","unstructured":"Onken JE, Bregman DB, Harrington RA, et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfus (Paris). 2014;54:306\u2013315.","journal-title":"Transfus (Paris)"},{"key":"5204_CR36","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2018. Available at: http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf . Accessed 24 July 2018."},{"key":"5204_CR37","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1172\/JCI67225","volume":"123","author":"N Zhao","year":"2013","unstructured":"Zhao N, Zhang AS, Enns CA. Iron regulation by hepcidin. J Clin Invest. 2013;123:2337\u20132343.","journal-title":"J Clin Invest"},{"key":"5204_CR38","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823:1434\u20131443.","journal-title":"Biochim Biophys Acta"},{"key":"5204_CR39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gut.2010.214312","volume":"61","author":"R Evstatiev","year":"2012","unstructured":"Evstatiev R, Gasche C. Iron sensing and signalling. Gut. 2012;61:933\u2013952.","journal-title":"Gut"},{"key":"5204_CR40","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1016\/j.crohns.2012.10.013","volume":"7","author":"RJ Basseri","year":"2013","unstructured":"Basseri RJ, Nemeth E, Vassilaki ME, et al. Hepcidin is a key mediator of anemia of inflammation in Crohn\u2019s disease. J Crohns Colitis. 2013;7:e286\u2013e291.","journal-title":"J Crohns Colitis"},{"key":"5204_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ndt\/gft251","volume":"29","author":"JE Onken","year":"2014","unstructured":"Onken JE, Bregman DB, Harrington RA, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transpl. 2014;29:833\u2013842.","journal-title":"Nephrol Dial Transpl"},{"key":"5204_CR42","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.14043","volume":"45","author":"A Aksan","year":"2017","unstructured":"Aksan A, Isik H, Radeke HH, et al. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45:1303\u20131318.","journal-title":"Aliment Pharmacol Ther"},{"key":"5204_CR43","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/ajg.2013.335","volume":"108","author":"W Reinisch","year":"2013","unstructured":"Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877\u20131888.","journal-title":"Am J Gastroenterol"},{"key":"5204_CR44","first-page":"199","volume":"14","author":"S Garcia-Lopez","year":"2016","unstructured":"Garcia-Lopez S, Bocos JM, Gisbert JP, et al. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus. 2016;14:199\u2013205.","journal-title":"Blood Transfus"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5204-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T19:09:44Z","timestamp":1720465784000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5204-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["5204"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5204-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"22 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Gary R. Lichtenstein has served as a consultant to Luitpold Pharmaceuticals, Inc., and Jane E. Onken has served on a Steering Committee and Advisory Board for Luitpold Pharmaceuticals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants performed in the four studies included in this post hoc analysis were in accordance with the ethical standards of the institutional review boards at each center and with the 1964 Helsinki Declaration (NCT00703937 and NCT00704353, NCT00704028, and NCT00982007;).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"Informed consent was obtained for all individual participants included in the four studies in the current analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}